CSF tau protein: a new prognostic marker for Guillain-Barré syndrome.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 17060576.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We measured the CSF tau protein levels in 26 patients with Guillain-Barré syndrome. The levels of the poor outcome group (Hughes grade at 6 months was between II and VI, n = 6) were higher than those of the good outcome group (0 or I, n = 20) (p < 0.0005). The higher levels of CSF tau may reflect axonal degeneration and could predict a poor clinical outcome in Guillain-Barré syndrome.
Medical subject headings
- Guillain-Barre Syndrome
- tau Proteins